Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Penumbra Inc (PEN)

Penumbra Inc (PEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,413,176
  • Shares Outstanding, K 39,162
  • Annual Sales, $ 1,195 M
  • Annual Income, $ 14,010 K
  • EBIT $ 173 M
  • EBITDA $ 197 M
  • 60-Month Beta 0.66
  • Price/Sales 10.35
  • Price/Cash Flow 109.42
  • Price/Book 9.10

Options Overview Details

View History
  • Implied Volatility 35.37% (+1.55%)
  • Historical Volatility 28.36%
  • IV Percentile 31%
  • IV Rank 16.89%
  • IV High 65.18% on 04/08/25
  • IV Low 29.31% on 08/12/25
  • Expected Move (DTE 18) 18.66 (5.93%)
  • Put/Call Vol Ratio 4.33
  • Today's Volume 16
  • Volume Avg (30-Day) 131
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 2,237
  • Open Int (30-Day) 3,329
  • Expected Range 296.23 to 333.55

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.12
  • Number of Estimates 8
  • High Estimate 1.24
  • Low Estimate 0.99
  • Prior Year 0.97
  • Growth Rate Est. (year over year) +15.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
284.95 +10.51%
on 12/04/25
321.38 -2.02%
on 12/22/25
+21.72 (+7.41%)
since 11/28/25
3-Month
221.26 +42.32%
on 11/03/25
321.38 -2.02%
on 12/22/25
+63.24 (+25.13%)
since 09/29/25
52-Week
221.26 +42.32%
on 11/03/25
321.38 -2.02%
on 12/22/25
+75.04 (+31.29%)
since 12/27/24

Most Recent Stories

More News
Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

ALAMEDA, Calif. , Dec. 29, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on...

PEN : 314.89 (-0.66%)
3 Profitable Stocks That Fall Short

3 Profitable Stocks That Fall Short

OMCL : 46.14 (-0.56%)
PEN : 314.89 (-0.66%)
PWP : 17.75 (+0.11%)
Zimmer Biomet Stock: Is ZBH Underperforming the Health Care Sector?

Despite Zimmer Biomet's underperformance relative to the broader healthcare sector over the past year, the stock is still viewed by analysts with moderate optimism.

ZBH : 90.53 (-0.26%)
XLV : 155.81 (-0.15%)
PEN : 314.89 (-0.66%)
3 Inflated Stocks We’re Skeptical Of

3 Inflated Stocks We’re Skeptical Of

CARS : 12.57 (unch)
PEN : 314.89 (-0.66%)
FSLY : 10.21 (-0.29%)
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 In Review: Penumbra (NYSE:PEN) Vs Peers

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 In Review: Penumbra (NYSE:PEN) Vs Peers

PEN : 314.89 (-0.66%)
Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

CORT : 79.82 (-3.42%)
ELAN : 22.65 (+0.22%)
LMAT : 82.96 (-0.98%)
PEN : 314.89 (-0.66%)
RMD : 242.85 (-0.78%)
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference

ALAMEDA, Calif. , Nov. 19, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 37 th Annual Healthcare Conference...

PEN : 314.89 (-0.66%)
1 Cash-Heavy Stock to Consider Right Now and 2 Facing Headwinds

1 Cash-Heavy Stock to Consider Right Now and 2 Facing Headwinds

AGL : 0.7378 (+1.65%)
KEYS : 206.85 (+0.39%)
PEN : 314.89 (-0.66%)
3 Cash-Producing Stocks We Steer Clear Of

3 Cash-Producing Stocks We Steer Clear Of

TREX : 35.51 (-0.42%)
PEN : 314.89 (-0.66%)
AGYS : 122.40 (+0.76%)
2 Healthcare Stocks to Keep an Eye On and 1 We Find Risky

2 Healthcare Stocks to Keep an Eye On and 1 We Find Risky

UHS : 226.11 (-0.67%)
PEN : 314.89 (-0.66%)
ELV : 348.38 (-0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access...

See More

Key Turning Points

3rd Resistance Point 325.68
2nd Resistance Point 322.73
1st Resistance Point 318.81
Last Price 314.89
1st Support Level 311.94
2nd Support Level 308.99
3rd Support Level 305.07

See More

52-Week High 321.38
Last Price 314.89
Fibonacci 61.8% 283.13
Fibonacci 50% 271.32
Fibonacci 38.2% 259.51
52-Week Low 221.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar